News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
444,551 Results
Type
Article (21540)
Company Profile (157)
Press Release (422854)
Section
Business (145262)
Career Advice (1159)
Deals (26338)
Drug Delivery (91)
Drug Development (58032)
Employer Resources (93)
FDA (9579)
Job Trends (9700)
News (243392)
Policy (21025)
Tag
Academia (910)
Alliances (34458)
Alzheimer's disease (690)
Approvals (9539)
Artificial intelligence (89)
Bankruptcy (223)
Best Places to Work (6967)
Biosimilars (68)
Biotechnology (77)
Cancer (645)
Career advice (961)
Cell therapy (119)
Clinical research (47481)
Collaboration (243)
Compensation (113)
COVID-19 (1231)
C-suite (78)
Data (730)
Diabetes (108)
Diagnostics (3106)
Drug pricing (91)
Earnings (59850)
Employer resources (85)
Events (69584)
Executive appointments (249)
FDA (9888)
Funding (203)
Gene therapy (101)
GLP-1 (510)
Government (1998)
Healthcare (8984)
Infectious disease (1287)
Inflammatory bowel disease (73)
Interviews (151)
IPO (11611)
Job creations (2971)
Job search strategy (878)
Layoffs (295)
Legal (5455)
Lung cancer (103)
Manufacturing (141)
Medical device (5097)
Medtech (5101)
Mergers & acquisitions (14782)
Metabolic disorders (354)
Neuroscience (870)
NextGen Class of 2024 (3338)
Non-profit (1422)
Northern California (932)
Obesity (222)
Opinion (179)
Patents (71)
People (42715)
Pharmaceutical (76)
Phase I (14718)
Phase II (20379)
Phase III (16090)
Pipeline (378)
Policy (70)
Postmarket research (1843)
Preclinical (5414)
Press Release (72)
Radiopharmaceuticals (185)
Rare diseases (153)
Real estate (4154)
Regulatory (14365)
Research institute (965)
Resumes & cover letters (177)
Southern California (816)
Startups (2420)
United States (8362)
Vaccines (225)
Weight loss (186)
Date
Today (77)
Last 7 days (490)
Last 30 days (2469)
Last 365 days (23334)
2024 (21382)
2023 (26371)
2022 (34931)
2021 (36766)
2020 (34460)
2019 (27142)
2018 (20935)
2017 (21944)
2016 (20699)
2015 (24749)
2014 (20141)
2013 (16910)
2012 (18178)
2011 (18800)
2010 (17769)
Location
Africa (499)
Arizona (85)
Asia (29293)
Australia (3900)
California (2055)
Canada (897)
China (158)
Colorado (91)
Connecticut (97)
Europe (60441)
Florida (275)
Illinois (190)
Indiana (134)
Maryland (278)
Massachusetts (1730)
Michigan (77)
Minnesota (146)
New Jersey (740)
New York (595)
North Carolina (483)
Northern California (932)
Ohio (86)
Pennsylvania (475)
South America (739)
Southern California (816)
Texas (271)
Washington State (201)
444,551 Results for "zosano pharma corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Biotech Beach
Zosano Pharma Provides Corporate Update
Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, provided a corporate update.
April 29, 2022
·
3 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
November 14, 2024
·
6 min read
Press Releases
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
November 8, 2024
·
10 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Press Releases
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
November 7, 2024
·
16 min read
Press Releases
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
November 7, 2024
·
7 min read
1 of 44,456
Next
